Guilan Dong

Intracranial efficacy of alectinib in ALK-positive NSCLC patients with CNS metastases—a multicenter retrospective study

Zihua Zou, Puyuan Xing, Xuezhi Hao et al. · BMC Medicine · 2022 · 43 citations · Full text

Medicine, Neurology, Oncology +17

Circulating tumor cells (<scp>CTCs</scp>)/circulating tumor endothelial cells (<scp>CTECs</scp>) and their subtypes in small cell lung cancer: Predictors for response and prognosis

Haohua Zhu, Yu‐Tao Liu, Yu Feng et al. · Thoracic Cancer · 2021 · 33 citations · Full text

Medicine, Cancer Biology, Oncology +17

Evaluation of Clinical Outcomes of Icotinib in Patients With Clinically Diagnosed Advanced Lung Cancer With <i>EGFR</i>-Sensitizing Variants Assessed by Circulating Tumor DNA Testing

Jiachen Xu, Zheng Liu, Hua Bai et al. · JAMA Oncology · 2022 · 15 citations · Full text

Medicine, Molecular Medicine, Oncology +17

&lt;p&gt;Icotinib as Adjuvant Treatment for Stage II-IIIA Lung Adenocarcinoma Patients with EGFR Mutation (ICWIP Study): Study Protocol for a Randomised Controlled Trial&lt;/p&gt;

Yutao Liu, Xuezhi Hao, Deruo Liu et al. · Cancer Management and Research · 2020 · 11 citations · Full text

Medicine, Oncology, Pharmacology +15

Genomic Alterations Identification and Resistance Mechanisms Exploration of NSCLC With Central Nervous System Metastases Using Liquid Biopsy of Cerebrospinal Fluid: A Real-World Study

Fangfang Shen, Naixin Liang, Zaiwen Fan et al. · Frontiers in Oncology · 2022 · 10 citations · Full text

Medicine, Molecular Genetics, Oncology +17